Cancer Research UK logo.
SearchDonate
  • Search

A study looking at treating children who have high risk acute lymphoblastic leukaemia with modified immune cells (CD19 TPALL)

Overview

Cancer types:

Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Children's cancers, Leukaemia

Status:

Results

Phase:

Phase 1/2

Details

This study used gene therapy to treat children with acute lymphoblastic leukaemia (ALL).

The study was for children and young people up to and including the age of 18. We use the term ‘you’ in this summary, but of course if you are a parent, we are referring to your child.

Recruitment start: 2 May 2012

Recruitment end: 4 November 2015

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Persis Amrolia

Supported by

Bloodwise

Children with Leukaemia

Department of Health

EU Framework 6

Moulton Charitable Foundation

University College London (UCL)

Last reviewed: 6 June 2017

CRUK internal database number: 7441

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.